<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30323785</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1664-2295</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>9</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Frontiers in neurology</Title>                <ISOAbbreviation>Front Neurol</ISOAbbreviation>            </Journal>            <ArticleTitle>Prevention of Brain Metastases.</ArticleTitle>            <Pagination>                <MedlinePgn>758</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2018.00758</ELocationID>            <Abstract>                <AbstractText>The incidence of brain metastases is projected to rise because survival rates of lung cancer, breast cancer, and melanoma continue to improve (1). The brain is being identified as a sanctuary site for harboring metastases despite excellent control of extracranial disease. This is thought to occur because the drug therapies that control extracranial disease have limited central nervous system (CNS) penetration. The development of brain metastases is a devastating diagnosis affecting both quality of life (QOL) and survival. Symptoms after diagnosis can include headache, nausea, vomiting, seizure, neurocognitive decline, and focal neurologic deficit. Some of these symptoms can be irreversible even after successful treatment of intracranial disease. Treatment of brain metastases often necessitates surgery and radiation. There have been some reports of systemic therapies offering an intracranial response however long-term data is lacking. These treatments for CNS metastases can also lead to neurocognitive sequelae impacting quality of life. Therefore, preventing disease from spreading to the brain is a topic that has generated much interest in oncology. Prophylactic cranial Irradiation (PCI) has been used in leukemia, small cell lung cancer (SCLC), and non-small cell lung cancer (NSCLC). While showing effectiveness in preventing intracranial disease development, its carries with it side effects of neurocognitive decline that can affect QOL. There are Clinical trials exploring novel delivery of PCI and concurrent neuroprotective drug therapy to try to mitigate these neurocognitive sequelae. These will be important trials to complete, as PCI has shown promise in controlling disease and prolonging survival in select patient populations. There are also drug therapies that have shown efficacy in preventing CNS metastases development. This review will explore the current therapies available to prevent CNS metastases.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Bovi</LastName>                    <ForeName>Joseph A</ForeName>                    <Initials>JA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>28</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Front Neurol</MedlineTA>            <NlmUniqueID>101546899</NlmUniqueID>            <ISSNLinking>1664-2295</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2001 Mar 1;19(5):1344-9</RefSource>                <PMID Version="1">11230477</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rep. 1983 Jul-Aug;67(7-8):675-82</RefSource>                <PMID Version="1">6307516</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1997 Oct;33(11):1752-8</RefSource>                <PMID Version="1">9470828</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1987 May 15;59(10):1683-91</RefSource>                <PMID Version="1">3470109</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):263-7</RefSource>                <PMID Version="1">9788403</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 1973 Sep;42(3):349-57</RefSource>                <PMID Version="1">4516522</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuro Oncol. 2013 Oct;15(10):1429-37</RefSource>                <PMID Version="1">23956241</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Feb 15;15(4):1452-9</RefSource>                <PMID Version="1">19228746</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 2005 Jul;49(1):109-15</RefSource>                <PMID Version="1">15949596</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):637-43</RefSource>                <PMID Version="1">1651304</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 1993 Jan;19(1):3-16</RefSource>                <PMID Version="1">8381714</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2002 Jun 15;99(12):4379-85</RefSource>                <PMID Version="1">12036865</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2018 May;19(5):672-681</RefSource>                <PMID Version="1">29602646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2006 Jan 20;24(3):491-9</RefSource>                <PMID Version="1">16421426</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2001 Jun 15;91(12):2394-400</RefSource>                <PMID Version="1">11413530</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2007 Aug 16;357(7):664-72</RefSource>                <PMID Version="1">17699816</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2001;1:5</RefSource>                <PMID Version="1">11432756</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Respir Med. 2017 Sep;5(9):707-716</RefSource>                <PMID Version="1">28734822</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Jan 20;29(3):279-86</RefSource>                <PMID Version="1">21135267</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Pediatr Oncol. 2002 May;38(5):320-8</RefSource>                <PMID Version="1">11979456</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2008 Apr 20;26(12):1993-9</RefSource>                <PMID Version="1">18421051</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 1998 Sep;21(3):193-201</RefSource>                <PMID Version="1">9857997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 1999 Aug 12;341(7):476-84</RefSource>                <PMID Version="1">10441603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2005 May 1;23(13):2955-61</RefSource>                <PMID Version="1">15860851</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Jan 20;29(3):272-8</RefSource>                <PMID Version="1">21135270</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1995 Aug;13(8):1880-92</RefSource>                <PMID Version="1">7636530</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2008 Apr;44(6):840-6</RefSource>                <PMID Version="1">18342502</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Haematol. 1978 Jun;7(2):313-37</RefSource>                <PMID Version="1">354833</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Nov;23(11):2919-24</RefSource>                <PMID Version="1">22782333</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2003 Jul 15;63(14):4021-7</RefSource>                <PMID Version="1">12874001</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2017 Aug 31;377(9):829-838</RefSource>                <PMID Version="1">28586279</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2003 Dec 1;21(23):4395-401</RefSource>                <PMID Version="1">14645430</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Neurol. 1978;19:579-92</RefSource>                <PMID Version="1">570349</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Dec 1;32(34):3810-6</RefSource>                <PMID Version="1">25349290</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hematol Oncol Clin North Am. 2004 Apr;18(2):355-72</RefSource>                <PMID Version="1">15094176</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rep. 1981 Sep-Oct;65(9-10):811-4</RefSource>                <PMID Version="1">6268295</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiat Res. 2004 Jul;162(1):39-47</RefSource>                <PMID Version="1">15222778</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Blood Cancer. 2005 Aug;45(2):139-43</RefSource>                <PMID Version="1">15714445</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2017 Aug;18(8):1049-1060</RefSource>                <PMID Version="1">28687377</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 1993 Oct;10(1-2):47-54</RefSource>                <PMID Version="1">8069603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neurooncol. 1984;2(3):253-9</RefSource>                <PMID Version="1">6389779</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):77-84</RefSource>                <PMID Version="1">20800380</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2016 Jul 26;316(4):401-409</RefSource>                <PMID Version="1">27458945</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 1974 Dec 5;291(23):1230-4</RefSource>                <PMID Version="1">4528982</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1992 Aug;10(8):1237-44</RefSource>                <PMID Version="1">1321893</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2007 Apr 1;25(10):1260-6</RefSource>                <PMID Version="1">17401015</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 1981 Feb 6;245(5):469-72</RefSource>                <PMID Version="1">7452872</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):971-7</RefSource>                <PMID Version="1">17446005</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):436-442</RefSource>                <PMID Version="1">29157748</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Mar 20;34(9):945-52</RefSource>                <PMID Version="1">26834058</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CNS Oncol. 2014 May;3(3):219-30</RefSource>                <PMID Version="1">25055130</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1995 Feb 1;87(3):183-90</RefSource>                <PMID Version="1">7707405</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">CNS metastases</Keyword>            <Keyword MajorTopicYN="N">SRS</Keyword>            <Keyword MajorTopicYN="N">WBRT</Keyword>            <Keyword MajorTopicYN="N">immunotherapy</Keyword>            <Keyword MajorTopicYN="N">prevention</Keyword>            <Keyword MajorTopicYN="N">targeted therapy (TT)</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30323785</ArticleId>            <ArticleId IdType="doi">10.3389/fneur.2018.00758</ArticleId>            <ArticleId IdType="pmc">PMC6172309</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>